These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 9205848)

  • 21. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valsartan and the kidney: review of preclinical and clinical data.
    Ruilope LM
    Adv Ther; 2001; 18(2):57-66. PubMed ID: 11446269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial dysfunction in spontaneously hypertensive rats: consequences of chronic treatment with losartan or captopril.
    Rodrigo E; Maeso R; Muñoz-García R; Navarro-Cid J; Ruilope LM; Cachofeiro V; Lahera V
    J Hypertens; 1997 Jun; 15(6):613-8. PubMed ID: 9218180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical experience with angiotensin II receptor antagonists.
    Brunner HR; Christen Y; Munafo A; Lee RJ; Waeber B; Nussberger J
    Am J Hypertens; 1992 Dec; 5(12 Pt 2):243S-246S. PubMed ID: 1290619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension.
    Goldberg AI; Dunlay MC; Sweet CS
    Am J Cardiol; 1995 Apr; 75(12):793-5. PubMed ID: 7717281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aliskiren and valsartan combination therapy for the management of hypertension.
    Epstein BJ
    Vasc Health Risk Manag; 2010 Sep; 6():711-22. PubMed ID: 20859542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of eplerenone added to renin-angiotensin blockade in hypertensive patients.
    Krum H; Nolly H; Workman D; He W; Roniker B; Krause S; Fakouhi K
    Hypertension; 2002 Aug; 40(2):117-23. PubMed ID: 12154100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New competition in the realm of renin-angiotensin axis inhibition; the angiotensin II receptor antagonists in congestive heart failure.
    Martineau P; Goulet J
    Ann Pharmacother; 2001 Jan; 35(1):71-84. PubMed ID: 11197588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin II receptor antagonism: losartan - sites and mechanisms of action.
    Triggle DJ
    Clin Ther; 1995; 17(6):1005-30. PubMed ID: 8750395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aliskiren/valsartan combination for the treatment of cardiovascular and renal diseases.
    Yarows SA
    Expert Rev Cardiovasc Ther; 2010 Jan; 8(1):19-33. PubMed ID: 20030022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The angiotensin II type 1 receptor blocker losartan in clinical practice: a review.
    Gavras HP; Salerno CM
    Clin Ther; 1996; 18(6):1058-67; discussion 1057. PubMed ID: 9001823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new class of antihypertensive therapy: angiotensin II receptor antagonists.
    Ellis ML; Patterson JH
    Pharmacotherapy; 1996; 16(5):849-60. PubMed ID: 8888079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II type 1 receptor blockers.
    Burnier M
    Circulation; 2001 Feb; 103(6):904-12. PubMed ID: 11171802
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of type 1 angiotensin II receptor blockers and angiotensin converting enzyme inhibitors in the treatment of hypertension.
    Weber MA
    J Hypertens Suppl; 1997 Dec; 15(6):S31-6. PubMed ID: 9493125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LDL apheresis with dextran sulfate and angiotension receptor antagonist (Losartan).
    Elicio N; Bertolini S; Garbarini R; Nardiello G; Elicio A; Aimale V
    Artif Organs; 1997 Apr; 21(4):334-5. PubMed ID: 9096809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Irbesartan: a new possibility in the treatment of hypertension].
    Rapi J
    Orv Hetil; 2002 May; 143(21):1187-92. PubMed ID: 12073539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood pressure variability, impaired autonomic function and vascular senescence in aged spontaneously hypertensive rats are ameliorated by angiotensin blockade.
    Sueta D; Koibuchi N; Hasegawa Y; Toyama K; Uekawa K; Katayama T; Ma M; Nakagawa T; Waki H; Maeda M; Ogawa H; Kim-Mitsuyama S
    Atherosclerosis; 2014 Sep; 236(1):101-7. PubMed ID: 25016364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term safety, tolerability and efficacy of aliskiren in combination with valsartan in patients with hypertension: a 6-month interim analysis.
    Chrysant SG; Murray AV; Hoppe UC; Dattani D; Patel S; Hsu H; Zhang J
    Curr Med Res Opin; 2008 Apr; 24(4):1039-47. PubMed ID: 18307835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiology patient page. Angiotensin receptor blockers.
    Terra SG
    Circulation; 2003 Jun; 107(24):e215-6. PubMed ID: 12821593
    [No Abstract]   [Full Text] [Related]  

  • 40. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
    Dahlöf B; Devereux R; de Faire U; Fyhrquist F; Hedner T; Ibsen H; Julius S; Kjeldsen S; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H
    Am J Hypertens; 1997 Jul; 10(7 Pt 1):705-13. PubMed ID: 9234823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.